Podcasts about cancer centers

This week we have Erik Jensen — actor, writer, director, and storyteller known for his roles in The Walking Dead and Mr. Robot, on the show!After recently completing treatment for stage-4 colorectal cancer, Erik joins us to talk about resilience, comics, creativity, and the stories that helped carry him through one of the hardest chapters of his life. We also dive into his award-winning film Brooklyn, Minnesota, acting alongside his daughter, and why he's now selling much of his personal comic collection to raise money for Sloan Kettering's Children's Cancer Center. This is a heartfelt conversation about survival, fandom, family, and the power of storytelling when we need it most.Special Guest - Eric Jensen IG: @ejensen123 Brooklyn, Minnesota Donate to Memorial Sloan Kettering Cancer CenterHost: Jared Gonzalez. Cohosts: Chaz Hawkins, Mauro Piquera. Master Chief Engineer: Jared Gonzalez. Editor: Jared Gonzalez. Graphics Editor: Jared Gonzalez. Digital Media Editor: Jared Gonzalez. Producer: Jared Gonzalez. ⁠https://linktr.ee/razzledazzleshowpodcast?utm_source=linktree_profile_share #razzledazzle #razzledazzleshow #podcast #popculture #TheWalkingDead #MrRobot #ErikJensen #comics #comicbooks #CancerAwareness #film #movies #storytelling #fyp #explore

C’è un’intelligenza discreta che lavora dentro di noi senza fermarsi mai. Regola il battito del cuore, il sonno, l’energia, la fame, l’umore, la concentrazione. Una regia silenziosa che ogni giorno cerca di mantenerci in equilibrio, anche quando noi non ce ne accorgiamo. A Obiettivo Salute in tavola entriamo dietro le quinte di questo straordinario sistema di autoregolazione insieme al professor Stefano Erzegovesi, medico, nutrizionista e psichiatra. Un viaggio tra cervello, alimentazione, ritmo biologico ed emozioni per capire come il corpo comunichi continuamente con noi attraverso segnali spesso sottili, ma preziosi.Nella Giornata Mondiale senza Tabacco, la puntata affronta poi il tema del fumo da una prospettiva diversa: non solo ciò che il tabacco danneggia, ma soprattutto ciò che il corpo è capace di recuperare quando smettiamo. Con il professor Marco Alloisio, Responsabile chirurgie specialistiche del Cancer Center di Humanitas e presidente di LILT Milano, parleremo della sorprendente capacità di rigenerazione dell’organismoNella seconda parte spazio agli ormoni e alla tiroide, minuscola ma potentissima direttrice d’orchestra del nostro benessere. Insieme alla professoressa Laura Fugazzola, Direttore della Struttura Complessa di Endocrinologia Santi Paolo e Carlo di Milano Ordinaria di endocrinologia all’Università degli Studi di Milano e Presidente della società europea della tiroide, sfateremo miti, falsi luoghi comuni e impareremo ad ascoltare meglio i segnali del corpo

BUFFALO, NY — May 15, 2026 — A new #review was #published in Volume 18 of Aging-US on May 4, 2026, titled “Cellular senescence: from pathogenic mechanisms to precision anti-aging interventions.” The study was led by first author Jian Deng and corresponding author Dong Yang from the Department of Targeting Therapy and Immunology, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China. In this comprehensive review, the authors examine how cellular senescence contributes to aging and age-related disease across multiple organ systems, while also highlighting the emerging complexity and functional diversity of senescent cell populations. Traditionally, senescent cells have been viewed primarily as harmful byproducts of aging, characterized by irreversible cell-cycle arrest and chronic inflammatory signaling. However, growing evidence suggests that some senescent cells also play beneficial physiological roles in tissue repair, embryonic development, and maintenance of tissue homeostasis. The review outlines how senescence develops in major tissues including the liver, lungs, kidneys, heart, adipose tissue, brain, and skin. Across these organs, aging-related cellular dysfunction is driven by a combination of oxidative stress, mitochondrial dysfunction, DNA damage, chronic inflammation, metabolic stress, telomere shortening, and environmental insults such as ultraviolet radiation and pollution. The authors describe how senescent cells accumulate in highly specialized cell populations—including hepatocytes, endothelial cells, fibroblasts, macrophages, astrocytes, and epithelial cells—where they can disrupt normal tissue architecture and promote chronic disease progression. Importantly, the article emphasizes that senescent cells are highly heterogeneous and should not be treated as a uniform population. Depending on the tissue context and biological environment, senescent cells may exert either protective or harmful effects. For example, certain senescent cells may help limit fibrosis or support wound healing, whereas others drive chronic inflammation, metabolic dysfunction, tissue degeneration, and cancer progression. This growing recognition of functional heterogeneity has prompted a major shift in anti-aging research away from indiscriminate elimination of senescent cells toward more selective and precision-based therapeutic strategies. “Based on these insights, this review summarizes the induction mechanisms of cellular senescence and the subsequent evolution of their functional phenotypes across diverse tissues.” Full press release - https://www.aging-us.com/news-room/precision-anti-aging-strategies-aim-to-target-harmful-senescent-cells-while-preserving-beneficial-ones Paper DOI - https://doi.org/10.18632/aging.206375 Corresponding author - Dong Yang – yangdong@wchscu.cn Abstract video - https://www.youtube.com/watch?v=HkJRwF8mp4A Keywords - cellular senescence, aging mechanisms, functional heterogeneity, precision anti-aging To learn more about the journal, please visit www.Aging-US.com​​ and connect with us on social media at: Bluesky - bsky.app/profile/aging-us.bsky.social ResearchGate - www.researchgate.net/journal/Aging-1945-4589 X - twitter.com/AgingJrnl Facebook - www.facebook.com/AgingUS/ Instagram - www.instagram.com/agingjrnl/ LinkedIn - www.linkedin.com/company/aging/ Reddit - www.reddit.com/user/AgingUS/ Pinterest - www.pinterest.com/AgingUS/ YouTube - www.youtube.com/@Aging-US Spotify - open.spotify.com/show/1X4HQQgegjReaf6Mozn6Mc MEDIA@IMPACTJOURNALS.COM

Morning Show 05-12-26 Hour 1 WVU Cancer Center-Restaurants by The Watchdog

On this episode of CEOs You Should Know, we spotlight two inspiring leaders making a real impact in the fight against cancer—Ann Regan and Beth Wild. Their conversation centers around the upcoming Rush to Crush Cancer Weekend, happening May 16–17, and the powerful mission behind it.From community-driven fundraising to groundbreaking research at the UPMC Hillman Cancer Center, this episode dives into how every mile ridden and every dollar raised is helping accelerate progress toward a world without cancer. Ann shares how the event has grown into a regional movement, while Beth offers insight into how those funds directly impact patient care and innovation.Whether you're a cyclist, a survivor, or someone looking to make a difference, this conversation is a reminder that together, we can turn hope into action—and action into results.https://www.rushtocrushcancer.org/

Great progress with treatment options for multiple myeloma as shared by Dr. Brandon Blue and his patient Tony. Mark asks pertinent questions in this episode. Why is multiple myeloma such a rare and difficult to diagnose cancer? Let's discuss with Dr. Blue in this episode of The Mark Bishop Show. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.

Great progress with treatment options for multiple myeloma as shared by Dr. Brandon Blue and his patient Tony. Mark asks pertinent questions in this episode. Why is multiple myeloma such a rare and difficult to diagnose cancer? Let's discuss with Dr. Blue in this episode of The Mark Bishop Show. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.

As Florida faces one of its worst wildfire seasons in years, a new study released at the American Association for Cancer Research annual meeting in San Diego, matches cancer rates in more than 90 thousand people over a decade to areas dealing with wildfire smoke. It finds the risk of certain cancers, including colorectal, more than doubled and risks of lung cancer nearly doubled. We speak with Matthew Schabath PhD, who leads the Cancer Epidemiology Program at Tampa's Moffitt Cancer Center, on how the researchers came up with those findings and how to apply them in your life. See omnystudio.com/listener for privacy information.

This episode features Marwan G. Fakih, MD - Medical Oncologist, Professor, Department of Medical Oncology & Therapeutics Research, Deputy Director, City of Hope Comprehensive Cancer Center, Division Chief, GI Medical Oncology, Co-director, Gastrointestinal Cancer Program at City of Hope. Here he shares his thoughts around potentially screening younger patients, due higher rates of colon cancer. He also discusses the importance of educating patients to not overlook potential symptoms, clinical trials, and more.

This episode features Marwan G. Fakih, MD - Medical Oncologist, Professor, Department of Medical Oncology & Therapeutics Research, Deputy Director, City of Hope Comprehensive Cancer Center, Division Chief, GI Medical Oncology, Co-director, Gastrointestinal Cancer Program at City of Hope. Here he shares his thoughts around potentially screening younger patients, due higher rates of colon cancer. He also discusses the importance of educating patients to not overlook potential symptoms, clinical trials, and more.

Dental peeps, this one is super personal… what happens when oral care is overlooked in cancer patients? We see these patients in our ops, but what happens when that patient is your Dad? My dad... My patient In this episode of the Tooth or Dare Podcast, I share the story of my father's battle with cancer and the parts of care that too often get missed. It began with the kind of phone call no one is ever ready for: “Your dad is coughing blood.” While I'm elbow deep in a 6mm pocket during an SRP.  From that moment on, life changed quickly. Emergency visits. Hospital admissions. A diagnosis that had likely been developing quietly for some time. The truth is, many lung cancers are not found until they are already advanced. But this episode is about more than the diagnosis and the outcome being tragic. It is also about something rarely talked about enough: oral health during cancer treatment. What I learned, what we created and how I shared it with the folks at the Cancer Center. If you want the same download, you can grab it here: Oral Cancer Products Digital Download from Toothlife.ca   We discuss: ⚪ How life can change in a single moment ⚪ Warning signs that were easy to dismiss: chronic headaches, rapid weight loss, persistent coughing ⚪ The emotional reality of watching a parent go through cancer ⚪ My memories of my dad: motorcycle rides, soccer, scuba diving, and the bond we shared. #1 dental dad.  ⚪ How families can be close, yet still silent about health concerns ⚪ What hospitals commonly recommend for oral care during treatment ⚪ Why “rinse with baking soda four times a day” is not enough   Clinical + real-world insight: ⚪ A firsthand look at how oral health can be overlooked in hospital settings ⚪ The absence of dental professionals on many cancer care teams ⚪ Four separate hospital admissions within 4 months and oral hygiene was never meaningfully addressed ⚪ The effects of radiation and cancer treatment can have on the mouth ⚪ Why preventive oral care should be part of treatment planning from day one At its core, this is not a story about my loss. It is a call to do better, and perhaps for us dental people who have not seen this journey firsthand to trust me and talk about this with our patients and teams.  Oral health is connected to overall health. Always has been, not new news to us, but to the folks at the hospital, I was speaking gibberish, apparently.   And when that connection is ignored in critical care, patients feel the consequences even if they don't know it. Increased risks of infections, lower immune response... the list goes on, and we discuss that here.  A simple takeaway: Awareness → Advocacy → Integration   Because patients deserve complete care, and that includes the mouth, too.  If you made it all the way down here, hit a like and share a comment. Until next time, Peace out peeps! ✌️

What do you do when the system meant to care for people… falls short? You build something better. On this episode of The Women's Eye Podcast, host Stacey Gualandi sits down with Annette Logan-Parker, founder and Chief Advocacy & Innovation Officer of Cure 4 The Kids—Nevada's only accredited outpatient pediatric cancer and rare disease treatment center. Annette's journey is both professional and deeply personal. After 15 years as a nurse, she witnessed firsthand how patients were often treated as line items and how providers struggled within a system that didn't always prioritize care. But everything changed when her own son suffered a catastrophic football injury—with rare, post-injury complications—leading to years of surgeries and navigating healthcare from the patient side. That experience became the catalyst for creating Cure 4 The Kids—a place where excellence, access, compassion, and innovation come together. As Annette said, "Every child deserves access to care—and a cure."

In this segment of Cancer Registry World, Laurie Kirstein, MD, FACS, a breast surgical oncologist in the Division of Surgical Oncology at Memorial Sloan Kettering Cancer Center and current Chair of the American College of Surgeons Commission on Cancer (CoC), discusses her vision and priorities for the CoC. Drawing on the power of cancer registry data, she highlights the essential role Oncology Data Specialists play in advancing cancer care, quality measurement, and program improvement. Tune in to hear how data-driven insights are shaping the future of oncology.

Developed by the Medical Student Membership Workgroup, the Urology Spotlight Series educates medical students about a particular subspecialty within urology, including common cases and procedures. In this episode, medical student Brandon Noorvash is joined by Dr. Sepehr Nowfar, a general urologist and Medical Director of the Cancer Center of Excellence at Unio Specialty Care - Los Alamitos, for a discussion on the field of general urology.

Dr. Roy Jensen introduces the season's focus on the people behind cancer research and hands hosting duties to Dr. Ronald Chen, chair of Radiation Oncology and associate director for Community Outreach and Engagement at The University of Kansas Cancer Center. Dr. Chen highlights the KU Cancer Center's K12 Paul Calabresi Career Development for Clinical and Translational Oncology program, which mentors and trains early career clinician-investigators, and interviews K12 scholar Dr. Yiduo Hu, a breast medical oncologist who joined KU after training at Yale and completing research and degrees at Case Western, Dana-Farber/Harvard, and Columbia University. Dr. Hu describes translational research as bridging communication between bench science and patient care, explains how the K12 Program's protected time and mentorship support his work on DNA damage repair and genome integrity in breast cancer, and discusses his newly activated pragmatic trial comparing two commonly used chemotherapy regimens for high-risk breast cancer. They also emphasize collaboration, including engagement with KU Cancer Center's PIVOT patient advocate group, to keep research patient-relevant and team-based. 00:00 Season Introduction 00:28 Guest Host Handoff 00:44 K12 Program Overview 01:18 Dr. Hu's Background 01:58 Translational Research Explained 03:08 K12 Support and Focus 04:09 Building A Clinical Trial 05:38 Protected Time Matters 06:22 Mentorship at KU Cancer Center 07:39 Community and PIVOT Collaboration 09:41 Career Reflections 10:33 Closing Thanks and Resources Links from this Episode: ·         Learn more about the K12 Paul Calabresi Career Development for Clinical and Translational Oncology Program To ensure you get our latest updates, follow us on the social media channel of your choice by searching for KU Cancer Center.

Some places don't just hold memories, they hold moments that changed everything.In this episode of The Cancer Caregiver Podcast, we explore a quiet but powerful part of caregiving that rarely gets talked about: why certain places like parking lots, hospital rooms, waiting areas can instantly bring you back to the hardest moments of your life.In this episode, we talk about:Why caregivers have strong emotional reactions to specific placesHow your brain stores medical trauma and caregiving memoriesWhy your body reacts before your mind can explain itThe concept of “caregiving geography” and how environments hold emotional weightWhy these reactions are not a sign that you're stuck but a sign of what you've carriedHow to gently reframe these places as evidence of your presence and strengthIf you've ever thought, “Why does this place still affect me?”This episode will help you understand—and feel less alone.

Morning Show 03-27-26 Hour 3 McCabe on Cancer Center, Guthrie interview by The Watchdog

Morning Show 03-24-26 Hour 2 Andrew Donaldson on ICE--Vision for Wheelin-Cancer center by The Watchdog

The University of Kansas Cancer Center is making available a one-time CAR T-cell therapy that could free blood cancer patients from the injection cycles of chemotherapy and radiation.

Leigh Ann sits down with Dr. Vershalee Shukla to explore how cancer screening is rapidly evolving beyond conventional tools like mammograms. Dr. Shukla explains why catching cancer at earlier stages can dramatically change treatment options and outcomes, and why safer screening matters more than ever as cancer rates rise in younger populations. Together, they discuss emerging technologies including QT ultrasound for breast screening, multi-cancer blood tests, whole-body MRI, and AI models designed to detect patterns long before symptoms appear. Dr. Shukla also breaks down the strengths and limitations of different liquid biopsy tests and explains why screening should be tailored to each person's age, risk factors, and history. Leigh Ann and Dr. Shukla also emphasize the importance of patient advocacy, personal responsibility, and seeking out newer technologies that may not yet be part of standard care.Product Discount Codes + LinksJuna: Website (Discount Code: LEIGHANN)Broc Shot: Website (Discount Code: LEIGHANNLINDSEY)Hoolest: Website (Discount Code: THEACCRESCENT10)Episode LinksC The Signs AIBe Sound Breast Scanning Guest InfoVincere Cancer Center - InstagramVincere Cancer Center - WebsiteRelated EpisodesPodcast Ep. 228: Dr. Lori Bouchard - The Missing Pieces in Cancer Care, Metabolism, Trauma, and Whole-Person HealingPodcast Ep. 213. Leigh Ann Lindsey - Potential Emotional Contributors to Breast Cancer Work w/Leigh AnnLearn: What is EVOX Therapy?Book: Schedule a Session or FREE Discovery CallMembership: What is The Healing Alchemy MembershipConnect w/Me & Learn MoreWebsiteInstagramTiktokYoutube

This week's Security Squawk episode isn't about phishing. It's about structural weakness. Three separate incidents. Three different industries. One uncomfortable pattern: the systems organizations trust most are expanding risk quietly — and in some cases, architecturally. First, a lawsuit that should make every board member pay attention. Marquis Software Solutions, a fintech serving 74 U.S. banks, is suing SonicWall. The allegation centers on SonicWall's cloud backup system, where firewall configuration backups were allegedly accessible and contained credentials — including MFA scratch codes. Those backups were reportedly used to compromise Marquis, leading to a ransomware incident and downstream exposure. What began as a scoped 5% customer exposure was later reported as potentially impacting all customers. This is not a misconfigured endpoint. This is a control-plane failure. For CEOs, this reframes vendor risk. It's no longer a questionnaire exercise. It's a litigation vector. If a security provider's design exposes authentication artifacts, your internal diligence may not matter. The liability chain now includes vendors and MSPs in a very direct way. For IT Directors, the operational question is simple: what exactly is inside your firewall backups? Are reusable authentication artifacts stored? Who can access vendor-hosted exports? If attackers obtain your configuration backups, can they replay your defenses? For MSPs, the exposure is real. If you manage firewall exports or MFA deployments, you are part of the architecture. And potentially part of the courtroom. Then we shift to UFP Technologies, a medical device manufacturer. Intrusion detected. Billing and shipping label systems disrupted. Data stolen or destroyed. Insurance expected to offset financial impact. But this isn't primarily a data story. Attackers disrupted order-to-cash and fulfillment velocity. In healthcare supply chains, slowing billing and labeling can create immediate executive escalation without touching the factory floor. Modern ransomware groups increasingly target business process choke points — ERP, labeling, scheduling — because leverage doesn't require full encryption anymore. For CEOs, “no material impact expected” is accounting language. Customers measure impact in delayed shipments. For IT leaders, the question becomes operational: can billing, labeling, and fulfillment functions recover independently? Are those systems segmented? Tested? Immutable? For risk managers and insurers, this represents a shift in underwriting focus — from endpoints to process resilience. Finally, the University of Hawaiʻi Cancer Center ransomware incident. Roughly 87,000 study participants directly impacted. But historical datasets, including Social Security numbers collected from driver's license and voter registration data dating back to 1998, expanded potential exposure to nearly 1.2 million individuals. They engaged the threat actors. They received a decryptor. They received “assurances” that data was destroyed. That's not verification. That's negotiation. The uncomfortable truth: legacy identity data becomes modern ransom currency. Research environments often have weaker governance than clinical systems, yet they can contain decades of sensitive identifiers. For boards, the issue isn't just security posture. It's data retention discipline. What obsolete identity data are you still holding? Why? For how long? And who owns the risk? Across these stories, three themes emerge: Control-plane trust is fragile. Operational choke points are the new leverage strategy. Data retention is compounded liability. Cybersecurity is no longer just about stopping intrusion. It's about architectural accountability and governance maturity. If you value independent, executive-level analysis without vendor spin, support the show at: buymeacoffee.com/securitysquawk The real question is this: Are your greatest cyber risks coming from external attackers — or from design decisions you haven't revisited in years?

Jamie McLennan, Will Crabtree, and Deborah Corn discuss the pros and cons of printing associations, what value these organizations provide, and how printers can use the right communities to strengthen collaboration, enhance operations, and keep their businesses moving forward. Mentioned in This Episode: Children's Cancer Center: https://childrenscancercenter.org/ Madi's Movement: https://madismovement.org/ PRINTING United Alliance: https://www.printing.org/ PRINTING United Expo: https://www.printingunited.com/ Jamie McLennan: https://www.linkedin.com/in/jamieprints DMR Graphics: www.dmr-graphics.com/ Innvoke: https://innvoke.com/  Will Crabtree: https://www.linkedin.com/in/willtheprinter/ Tampa Media: https://tampa.media/ Gorilla Consultants: https://gorillagurus.com Deborah Corn: https://www.linkedin.com/in/deborahcorn/ Print Media Centr: https://printmediacentr.com Subscribe to News From The Printerverse: https://printmediacentr.com/subscribe-2 Girls Who Print: https://girlswhoprint.org Project Peacock: https://ProjectPeacock.TV

In this episode, Dr. Theodoros Teknos, President and Scientific Director of the University Hospitals Seidman Cancer Center at University Hospitals Cleveland Medical Center and Deputy Director of the Case Comprehensive Cancer Center, joins the podcast to discuss balancing cancer center ambitions with broader health system priorities. He shares perspectives on when restraint versus expansion is necessary and how machine learning is beginning to shape cancer research, strategy, and care delivery.

In this segment of Cancer Registry World, we explore the critical need to define and capture cancer recurrence data—and the challenges registries face today. Dr. David Byrd, surgical oncologist and former chair of the American Joint Committee on Cancer (AJCC), shares insights from his work leading a multidisciplinary workgroup to establish meaningful, standardized approaches to recurrence data collection.

Topic: Why More Cancer Is Being Diagnosed in Younger AdultsIntro: We're seeing more cancers diagnosed in adults under 50—why is this happening?Dr. Brittany Case, medical oncologist at Southern Cancer Center, is here to discuss what we know, what we don't know, and how care is changing.

A famous designer will help cancer patients on Chicago's south side and south suburbs. A grant from the Ralph Lauren Corporate Foundation will establish the first cancer center bearing his name in the Midwest and the fourth in the country.

A famous designer will help cancer patients on Chicago's south side and south suburbs. A grant from the Ralph Lauren Corporate Foundation will establish the first cancer center bearing his name in the Midwest and the fourth in the country.

A famous designer will help cancer patients on Chicago's south side and south suburbs. A grant from the Ralph Lauren Corporate Foundation will establish the first cancer center bearing his name in the Midwest and the fourth in the country.

While getting an annual mammogram is pretty commonplace for many women, the testing isn't always accessible for many reasons: language barriers, a lack of insurance or being underinsured, the inability to get to a clinic, and childcare issues, just to name a few. Dana-Farber Cancer Institute's Mammography Van has a solution for that. The hospital has packed up a full mammography suite into a van, making stops around Greater Boston to ensure everyone can get a scan who needs it. Tia Goodman, the Program Director for the Mammography Van, joins the show this week with details.See omnystudio.com/listener for privacy information.

Interview with the Rev. Kate Dunn and Tom Anderson

Today's Guest is Dr. Timothy Mullett, Medical Director of the Markey Cancer Center Affiliate Network at University of Kentucky Healthcare, enhancing access to high-quality cancer services and programs through collaboration with community hospitals. Our vision is for Kentuckians and those from surrounding states to have access to excellent cancer care.

Closing the Gap: Understanding Gender Disparities in Bladder Cancer Care, hosted by Martha K. Terris, MD, FACS, is a limited series spotlighting unique considerations for bladder cancer diagnosis and treatment among women. Dr Terris is department chair and a professor in the Department of Urology, the Witherington Distinguished Chair in Urology, and co-director of the Cancer Center at the Medical College of Georgia at Augusta University. In the final part of this 3-part series, Dr Terris discussed how the early diagnosis of bladder cancer presents a significant challenge, particularly in female patients, who are frequently diagnosed at a later stage of the disease and subsequently respond less favorably to treatment modalities. A crucial component of early detection is the rigorous evaluation of hematuria, she emphasized. Microhematuria is defined strictly by microscopy. Reliance solely on a dipstick test is insufficient; any positive dipstick result necessitates a microscopic examination, she explained. Furthermore, patients currently receiving anticoagulation therapy do not bypass the standard workup, she noted. If hematuria is identified alongside a urinary tract infection or gynecological issue, the urine should be rechecked once the co-existing problem has cleared, she advised. Risk assessment must consider both common and less-recognized factors, particularly in women, according to Terris. Standard risks include exposure to cyclophosphamide or ifosfamide, Lynch syndrome, chronic indwelling Foley catheters, benzene/aromatic amine exposure, and smoking, she added. However, uro-oncologists must actively assess female patients for occupational exposures not traditionally associated with bladder cancer, she said. Patients presenting with microhematuria should be stratified into low-, intermediate-, or high-risk groups, Terris continued. The gold standard evaluation for high-risk patients is a cystoscopy and CT urogram, she reported. The CT urogram involves cross-sectional imaging of the abdomen and pelvis with and without contrast, incorporating delayed images to optimally visualize the renal pelvis and ureters for potential filling defects, she noted. If patients cannot tolerate contrast, an MR urogram is the primary alternative, she stated. If neither CT nor MR urogram can be performed, the default workup is non-contrast CT combined with cystoscopy and retrograde pyelograms, although this requires general anesthesia, she explained. Given that women are often diagnosed with bladder cancer late and face poor outcomes with advanced disease, maintaining a heightened awareness and low threshold for investigation is critical, Terris concluded.

Dr. Weisi Yan joins the show to discuss his path to medicine, the latest advancements in radiation oncology and the UK Markey Cancer Center's upcoming Lung Cancer Forum scheduled for Dec. 11.  Learn more about Weisi Yan, MD, PhD 

Recognition is no longer just about t-shirts or medals - it's about meaning. Thoughtful, mission-driven recognition strategies can deepen fundraisers' emotional connection and inspire long-term loyalty.In this episode, Marcie Maxwell talks with Meredith Perkins, Director of Peer-to-Peer Fundraising at The University of Texas MD Anderson Cancer Center. Meredith shares how her team has evolved recognition from transactional to transformational, creating experiences that honor fundraisers' motivations and celebrate their impact.From weaving MD Anderson's mission to eliminate cancer into every recognition moment to reimagining branded products with purpose, Meredith offers practical ways to make participants feel valued and connected. She also dives into how feedback and metrics guide continuous improvement, ensuring each recognition effort aligns with participant expectations and program goals.Together, we'll explore:How to design recognition programs that strengthen mission connection and emotional engagementCreative ways to recognize and reward fundraisers across participation levels and yearsPractical methods for measuring impact and evolving recognition strategies for sustained success​Mentioned Linkswww.MDAnderson.org/Fundraisewww.MDAnderson.org/BootWalkwww.MDAnderson.org/DIYwww.MDAnderson.org/Remember​Stay Connected on LinkedInConnect with MeredithConnect with MarcieConnect with the Peer-to-Peer Professional Forum (00:00) - Welcome to The P2P Soap Box

Isabel González entrevista a la Dra. Silvia Pérez Rodrigo.

Closing the Gap: Understanding Gender Disparities in Bladder Cancer Care, hosted by Martha K. Terris, MD, FACS, is a limited series spotlighting unique considerations for bladder cancer diagnosis and treatment among women. Dr Terris is department chair and a professor in the Department of Urology, the Witherington Distinguished Chair in Urology, and co-director of the Cancer Center at the Medical College of Georgia at Augusta University. In part 2 of this 3-part series, Dr Terris discussed the disparities in treatment and outcomes for women with bladder cancer. Although bladder cancer is less common in females than in males, female patients tend to have significantly worse outcomes, Terris explained. Delayed diagnosis is a contributing factor, but the exact reasons for the poorer prognosis are not fully understood, she emphasized. Treatment difficulties begin surgically, according to Terris. From a surgical perspective, she noted that, performing a cystectomy on a woman is more challenging due to factors like pelvic varicosities and differing fat distribution, which complicate stoma creation. In terms of medical treatment, Terris also explained that women exhibit worse tolerability and higher rates of discontinuation of immunotherapy, and that they often experience poor efficacy outcomes regardless of whether they complete the course of treatment. These differences between men and women may be linked to factors such as hormonal influences or antibody introduction during pregnancy. Conversely, classic cisplatin-based neoadjuvant chemotherapy followed by radical cystectomy have been shown to have similar overall survival and disease-free survival in eligible female and male patients. Biologically, Terris also reported that tumors in women may exhibit more effective immune escape mechanisms, possibly connected to differences in the bladder microbiome. The presence of bacteria in bladder tumors has been found to be enriched in patients who did not respond to neoadjuvant chemotherapy, which is relevant as women are more prone to bladder colonization, she added. Overall, Terris emphasized that oncologists must be aggressive in treating women with bladder cancer, despite surgical complexities, and highlighted that early detection is key.

The opening of a $56 million Taranaki Cancer Centre in New Plymouth is being described as life changing for people living with the disease in the region, and for the professionals who care for them. About 300 patients a year have had to make the three-hour trek to Palmerston North for radiation treatment - lasting sometimes just minutes - but now 80 percent of radiation treatment will be done locally. Taranaki Whanganui reporter Robin Martin was at the opening.

Closing the Gap: Understanding Gender Disparities in Bladder Cancer Care, hosted by Martha K. Terris, MD, FACS, is a limited series spotlighting unique considerations for bladder cancer diagnosis and treatment among women. Dr Terris is department chair and a professor in the Department of Urology, the Witherington Distinguished Chair in Urology, and co-director of the Cancer Center at the Medical College of Georgia at Augusta University.  In part 1 of this 3-part series, Dr Terris discussed the prevalence of bladder cancer in women, as well as reasons for diagnostic disparities that contribute to poor treatment outcomes. She noted that this disease is often diagnosed at later stages in women than in men, often resulting in diagnoses of more advanced disease and translating to poorer outcomes. She added that although female patients represent a minority of those with urothelial carcinoma, retrospective data indicate that women tend to be diagnosed at later stages and consequently experience worse survival rates, regardless of the disease stage. Dr Terris identified several theories explaining why this diagnosis delay occurs. One possible reason is patient-related: women may be less likely than men to consult a physician when they notice blood in their urine because they may be conditioned to dismiss blood if they experience menstrual bleeding. However, physician behavior and bias also contribute to diagnostic disparities, Terris said. Women with suspected hematuria typically receive fewer imaging tests, she continued. Additionally, physicians may be biased, attributing hematuria to uterine bleeding, menstruation, or other benign causes.  Overall, Terris emphasized that early detection is key. If there is any suspicion of a malignancy, patients should be referred directly to a urologist, she stated. Urologists should be willing to work up cases that might ultimately be recurrent urinary tract infections or radiation cystitis to avoid undiagnosed cases of bladder cancer in women, she concluded.

“Another sign is not the answer—it dilutes the message.” - Corinn Soro Today on the pod, Cheryl sits down—virtually—with Senior Planner and Interior Designer Corinn Soro of Roswell Park Comprehensive Cancer Center in Buffalo, NY for a deep dive into wayfinding that actually works: why “visual pollution” erodes attention, how de-crapification clarifies intent, and where evidence-based choices can transform the patient journey from disorientation to ease.  Expect real examples—subway-style maps that set expectations at a glance, pictograms that land when words won't, and donor walls designed to evolve rather than date out—plus the small, cumulative tweaks that lower stress for visitors and staff alike.  Today's conversation is about design as reassurance, translating research into decisions that cut through noise and hand back control the moment someone walks through the door. What We Cover A 17-year-old's spark: geriatric care, neuroplasticity, and the built environment London roots: learning research methods alongside OTs and PTs; universal design for all bodies Evidence-Based Design in action: NICU decisions (sound, circadian light, infection control) backed by research “Visual pollution” vs. visual cues: the case for ruthless editing (“de-crapification”) before adding signs Wayfinding that works under stress: step-by-step instructions, few decision points, and reassurance cues Designing for low literacy: a color-and-letter “subway” system, line-of-travel markers, and proximity intuition Pictograms that actually communicate: testing, swapping out abstractions, and kid-friendly icons Measuring ROI: missed appointments, staff disruptions, and the real cost of poor wayfinding In-house rhythm at a research hospital: tight feedback loops, quick iterations, and process fixes Donor walls that age well: digital storytelling, magnetic plaques, and durable substrates Advocacy and pipeline: AMFP Upstate NY, craft labor realities, and manufacturing shifts ahead Big wish list: self-cleaning floors (for hospitals…and home) Why post-occupancy evaluations could prevent future design disasters (and why they rarely happen) Key Takeaways Edit before you add. Wayfinding succeeds when clutter is removed and destinations are made legible through architecture, lighting, and contrast—not just more signs. Design for the stressed brain. Fewer decision points + stepwise reassurance beat complex directions every time. Evidence accelerates approvals. EBD turns subjective taste debates into science-backed decisions leadership can green-light. Symbols > sentences. Tested pictograms improve comprehension across languages, ages, and literacy levels. Iterate in the wild. Being embedded with clinicians and patients surfaces quick wins you'll never catch from afar. Memorable Quotes from Corinn Soro “Another sign isn't the answer—it dilutes the message.” “Wayfinding is about giving choice back to patients when so much else is out of their control.” “If a space is ‘too quiet' for the engineer, it's probably just right for the neonates.” “Healthcare design is a team sport.” Resources & Links Roswell Park Comprehensive Cancer Center — https://www.roswellpark.org/ AMFP Upstate New York Chapter — https://amfp.org/upstate-new-york Fiona Finer, the Interior Designer (ages 3–8) — https://www.amazon.com/Fiona-Finer-Interior-Designer-Corinn/dp/1720664889 EDAC Certification (Evidence-Based Design) — https://www.healthdesign.org/certification-outreach/edac Hablamos Juntos pictograms — https://www.theicod.org/resources/news-archive/segd-and-hablamos-juntos-introduce-new-universal-symbols-in-health-care Sisters of Charity Hospital (Buffalo, NY) — NICU project mentioned — https://www.chsbuffalo.org/sisters-of-charity-hospital/ Past HID2.0 episode featuring Tama Duffy Day — Episode 20 https://healthcareidpodcast.libsyn.com/2019/09 Connect with Corinn Soro Email: corinn.soro@roswellpark.org LinkedIn: https://www.linkedin.com/in/corinn-soro-14859ab/ Our Industry Partners The world is changing quickly. The Center for Health Design is committed to providing the healthcare design and senior living design industries with the latest research, best practices and innovations. The Center can help you solve today's biggest healthcare challenges and make a difference in care, safety, medical outcomes, and the bottom line.  Find out more at healthdesign.org. Additional support for this podcast comes from our industry partners: The American Academy of Healthcare Interior Designers The Nursing Institute for Healthcare Design Learn more about how to become a Certified Healthcare Interior Designer®  by visiting the American Academy of Healthcare Interior Designers at: https://aahid.org/. Connect to a community interested in supporting clinician involvement in design and construction of the built environment by visiting The Nursing Institute for Healthcare Design at https://www.nursingihd.com/ ------------ The world is changing quickly. The Center for Health Design is committed to providing the healthcare design and senior living design industries with the latest research, best practices and innovations. The Center can help you solve today's biggest healthcare challenges and make a difference in care, safety, medical outcomes, and the bottom line.  Find out more at healthdesign.org. Additional support for this podcast comes from our industry partners: The American Academy of Healthcare Interior Designers The Nursing Institute for Healthcare Design Learn more about how to become a Certified Healthcare Interior Designer®  by visiting the American Academy of Healthcare Interior Designers at: https://aahid.org/. Connect to a community interested in supporting clinician involvement in design and construction of the built environment by visiting The Nursing Institute for Healthcare Design at https://www.nursingihd.com/ FEATURED PRODUCT Porcelanosa are at the forefront of sustainable manufacturing – clients not only expect this of their suppliers but are increasingly asking to see the receipts. Let's unpack this, did you know that hundreds of preeminent members of The American Institute of Architects –  The AIA – have signed the AIA Materials Pledge? The Pledge is aligned with the Mindful Materials Common Materials Framework – the CMF. This is just one, very impressive example of how the movement to support decision making for building product selection has reached new highs. We can see these explained as 5 pillars of sustainability: (The first) - Human Health: Focusing on avoiding hazardous substances and promoting well-being. (Then) - Social Health & Equity: Addressing human rights and fair labor practices throughout the supply chain. (The third) is Ecosystem Health: Supporting the regeneration of natural resources and habitats. (This is followed by) Climate Health: Reducing and sequestering carbon emissions. (And the fifth pillar) is The Circular Economy: Promoting a zero-waste future through design for resilience, adaptability, and reuse. I mentioned the receipts -How do we track the progress of these principles and values? Without measurement, there's no clear path to improvement or accountability. The Mindful Materials CMF maps a framework of over 650 sustainability factors across those five key areas. A cornerstone of material health transparency is an Environmental Product Declaration EPD report. The best are independently verified for accuracy by third party certification bodies – a company cannot mark their own report cards. EPDs are highly technical documents containing scientific information on the embodied carbon used to manufacture products. I have just read and included here an EPD for a Porcelanosa Tile – there are upwards of 1000 data inputs to quantify its climate impact. Porcelanosa offer the confidence and certainty of knowing that every tile, every slab of XTONE porcelain or KRION solid surface  has a Product Specific EPD – when architects and designers work with these materials they are making a robust decision to meet their sustainable design goals. To learn more about how Porcelanosa help their customers design for resiliency, here is a link to their comprehensive Corporate Social Responsibility Report: https://www.porcelanosa.com/en/corporate-social-responsibility/

Rachel Cliffe, Community Outreach and Partnerships Manager at Siteman Cancer Center, discusses her role in cancer prevention and community education. She highlights the importance of healthy habits like eating well, exercising, and avoiding smoking to reduce cancer risk. Rachel shares her experience with recent partnerships with local businesses in St. Louis to help raise cancer awareness. Check out St. Louis Mom's latest reel of Ovarian Cancer Prevention in partnership with Siteman Cancer Center!This podcast episode is sponsored by Siteman Cancer Center: National Leaders in Cancer Treatment & Research.Rachel Cliffe is a Telly Award–winning producer at Siteman Cancer Center at Barnes-Jewish Hospital and WashU Medicine, where she's spent seven years advancing the organization's mission to educate and empower the St. Louis community on cancer prevention and early detection. As Community Outreach & Partnerships Manager, Rachel develops innovative collaborations with local organizations, businesses, venues, and community groups to promote healthier lifestyles and raise awareness about the critical importance of early and routine cancer screenings. She also leads production of Siteman's award-winning podcast, ‘This Is Cancer', a patient-centered series featuring conversations with WashU Medicine physicians that aim to inform, uplift, and support individuals navigating cancer treatment, caregiving, and beyond. Outside of work, Rachel enjoys taking her kids to local parks, cooking, spending time with friends and family, and discovering new restaurants in St. Louis.We hope you enjoyed this podcast episode! To learn more about Moms of the Lou you can go to stlouismom.com or follow us on Instagram and Facebook. You can listen to the podcast on Apple Podcast and Spotify. And don't forget to rate and review so more people can tune in! This episode was produced by the St. Louis Mom. It was recorded and edited by STL Bucketlist Studios in St. Louis, Missouri. 

Time for a Check Up - Sean Sullivan talked to Director of Research Karla Childers from the Southern Cancer Center about the type of clinical trials.  

On this month's Time for a Check Up Sean Sullivan talked to Southern Cancer Center's Karla Childers about Clinical Trials.  Clinical trial are important to test medications that can help in the future!  How does it work??  Listen here:

The Kearney Regional Medical Center – owned by Bryan Health – and Cancer Partners of Nebraska are coming together to open the Kearney Cancer Center, a 25,000-square-foot facility dedicated to cancer treatment. The center includes a positron emission tomography (PET) scanner to detect early signs of cancer, a linear accelerator for delivering radiation to treat tumors, and infusion bays with views of Yanney Park for chemotherapy patients. It will also offer on-site lab and diagnostic imaging, access to national clinical trials and certified mastectomy fitting.

Today, we’re bringing you the best from the KUOW Newsroom… The Fred Hutchinson Cancer Center celebrated its 50th anniversary this week - the center has evolved from a scrappy lab doing what some considered risky science, into one of the top cancer centers in the world. International students have brought needed revenue to colleges in recent years, especially community colleges where local enrollment has fallen… But getting permission to study in the U-S has gotten harder under the Trump administration. And September 2nd marked 80 years since the end of World War II. Hear from veterans’ families, and a historian working to preserve personal memories of World War II. We can only make Seattle Now because listeners support us. Tap here to make a gift and keep Seattle Now in your feed. Got questions about local news or story ideas to share? We want to hear from you! Email us at seattlenow@kuow.org, leave us a voicemail at (206) 616-6746 or leave us feedback online.See omnystudio.com/listener for privacy information.

Today on Sauna Talk, we welcome a very special guest. Dr. Hans Hägglund. Who is Dr. Hans Hägglund? Hans Hägglund MD, PhD, is a medical doctor and professor at Uppsala University, in Northern Sweden. Professor Hägglund has a strong research back ground in clinical research within medicine. He graduated from Karolinska institute, Sweden and did his post doc at Fred Hutchinson Cancer Research Center in Seattle, USA. Between 2013 and 2018 he served as the director of the Cancer Center at Uppsala University Hospital. Professor Hägglund also had the position as the national cancer coordinator at The Swedish Association of Local Authorities and Regions (SALAR) between 2019-2022. He currently holds a position as a senior consultant at Karolinska University Hospital in Stockholm, which is where we catch up with him for this episode of Sauna Talk. Hot facts On this episode of Sauna Talk, we recognize that Hans Hägglund is a man who wears many hats in the world of health, wellness, and sauna culture. Hans is an affiliated researcher at the Center for Resilient Health at the Stockholm School of Economics, and co-founder of Vision Zero Cancer in Sweden. Known by many as the “sauna doctor,” he serves at the Swedish Sauna Academy, sits on the board of the Sauna Research Institute and the International Sauna Association, and played a key role in organizing the XVII International Sauna Congress in Haparanda/Tornio back in 2018. His book The Sauna Book – Hot Facts on Sauna and Health, published in Swedish in 2020, has attracted wide attention for the way it bridges science and tradition. We explore why sauna and cold bathing are seeing a surge in global interest, and what challenges remain in researching their health benefits. Hans shares his thoughts on why sauna bathing should be considered alongside traditional medicine, gives us a glimpse into the new book he's writing, and reflects on how prevention can be far more cost-effective than treatment. Along the way, we discuss his professional journey, the boards he serves on, and even his earliest sauna memories. And, of course, we'll hear his take on one of my favorite questions: from a Swedish — and global — perspective, what's the most misunderstood thing about sauna that he wishes more people knew? Let's welcome Dr. Hans Hägglund to Sauna Talk. Here's a short intro for social medializing: “In this episode of Sauna Talk, I sit down with Hans Hägglund — “the sauna doctor” — affiliated researcher, co-founder of Vision Zero Cancer, and board member of the International Sauna Association. We dive into the rising global interest in sauna and cold bathing, the challenges of sauna research, and why prevention may be the most powerful medicine. Hans also shares personal sauna memories, his upcoming book project, and what he believes is the most misunderstood thing about sauna.” Punchy one sentences: From Swedish sauna congresses to cold plunges, Hans Hägglund brings the heat — and the science — to Sauna Talk. What's the most misunderstood thing about sauna? “The sauna doctor” Hans Hägglund has a prescription. Sauna, science, and a splash of cold water — Hans Hägglund joins Sauna Talk for a deep dive into the health of heat.

This episode features Joanna Weiss, Executive Vice President and CFO at Moffitt Cancer Center, who shares her journey through finance and revenue cycle leadership. She discusses key priorities including financial stabilization, strategic growth, AI-driven automation, and how the CFO role is evolving to support long-term innovation and patient-centered care.